# Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrillation Patients (CAAN-AF)

> **NCT01522898** · NA · COMPLETED · sponsor: **University of Adelaide** · enrollment: 145 (actual)

## Conditions studied

- Heart Failure
- Atrial Fibrillation

## Interventions

- **PROCEDURE:** AV nodal ablation
- **DRUG:** Medical Ventricular Rate Control

## Key facts

- **NCT ID:** NCT01522898
- **Lead sponsor:** University of Adelaide
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2020-08-31
- **Final completion:** 2020-08-31
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2020-11-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01522898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01522898, "Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrillation Patients (CAAN-AF)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01522898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*